Abstract: The current invention provides novel nitinol alloys, particularly, nitinol alloys containing a third metallic element referred to as ternary nitinol alloys. Accordingly, the current invention provides nitinol alloys including, but not limited to, Nickel-Titanium-Chromium (NiTiCr) and Nickel-Titanium-Tantalum (NiTiTa). The current invention also provides implants manufactured from the ternary nitinol alloys. The implants comprise the ternary nitinol alloys and are, optionally, surface treated to promote anti-thrombogenicity and biocompatibility, for example, through magnetoelectropolishing (MEP). Accordingly, the current invention provides nitinol alloys and implants comprising the nitinol alloys that reduce the risk of clotting due to stagnant blood flow, eliminate flushing, and minimize infection and damage to blood vessels.